Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that Ascletis ...
Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic ...
In A Nutshell Dissolving microneedle patches embedded with microscopic bubbles deliver three acne medications simultaneously, ...
The open-label Phase 3 trial evaluated the safety of ASC40 (denifanstat) tablets in patients with moderate to severe acne over a 40-week period. Denifanstat is being developed by Ascletis for acne in ...
Back pain is one of the most common of all health complaints and, for nearly six million people, the pain is constant and ...
It might be tempting to pick at skin moles, especially if you want to save yourself a dermatologist visit, but Dr Max ...
Here's how to handle those pesky bumps.
The landscape beneath Antarctica's icy surface revealed in unprecedented detail 9 fruits with the most soluble fiber for ...
Targeted therapies have been moved forward in the treatment of both pemphigus and pemphigoid diseases, a factor behind an ...
How PCOS Is Affecting One In Four Women. --> Polycystic Ovary Syndrome (PCOS) is a hormonal disorder that is silently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results